ArticleFrontiers in molecular biosciences2022

Structural Characterization of the Full-Length Anti-CD20 Antibody Rituximab.

Benny Danilo Belviso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.